Cibus Global LLC (CBUS) is a Healthcare · Biotechnology company listed on NASDAQ. Price $1.64 (+0.61%), Market cap $0.11B, 52-week low–high $1.16 ~ $4.05.
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Financial statements, price targets, institutional (13F) holdings and related news for Cibus Global LLC are updated in real time on BlackAll Trade.
Cibus Global LLC trades at $1.64 (+0.61%). Real-time quotes and charts are available on BlackAll Trade.
Cibus Global LLC has a market cap of about $0.11B.
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals